SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 58.08+0.9%Dec 11 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott H. Davis who wrote (2662)1/23/2001 11:08:21 PM
From: jj_   of 52153
 
and thus eliminate the need to use fetal tissues each time as a source

if they have found a way to genetically reproduce the stem cells that everyone is up in arms about then I guess that problem is solved and I want to invest in the company/companies who are the leaders with genetically engineered fetal stem cells. Do you know any this specific?

My understanding is the ethics concern is the potential compromising of humans and fetuses for the development of more fetal tissue.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News